Endovascular

BEST-CLI and BASIL 2: How Should Findings Impact Care?

23 min.

Increasing Diversity in Peripheral Vascular Disease Research: The Elegance Registry

21 min.

The Pharmaco-Invasive Approach to CLTI

7 min.

Angiographic Core Laboratory Data Insights into CLTI

9 min.

Real-world Outcomes in CLTI: Impacts of Regional Variability and Race

8 min.

Exemplary Cases From the LIFE-BTK Trial

20 min.

Essential Features of the Core Laboratory Protocols: Lessons Worth Learning

17 min.

LIFE-BTK: The Top Line Results and Beyond

21 min.

Primary Outcomes of the Esprit™ BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions: The LIFE-BTK Randomized Controlled Trial

21 min.

Deep Vein Arterialization for No-Option CLTI Patients: Technology and Clinical Program Update

10 min.

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

9 min.

Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial

8 min.

Keynote Lecture: Innovation in BTK Intervention: Clinical and Technical Lessons Learned From Recent DCB and DES Trials

10 min.

Best CLTI Case of the Year

13 min.

Worst CLTI Case of the Year

13 min.

Complex Tibial Case Review

11 min.

Drug-Coated Balloons BTK: What’s the Latest in the Field?

17 min.

Deep Venous Arterialization: Indications, Technique, and Data

10 min.

New BTK Bioresorbable Stent Technology: Life BTK, The MOTIV-BTK Trial and R3 Clinical Programs

10 min.

Severe Calicum BTK: Novel Techniques From Within and Without

10 min.

Atherectomy BTK: What’s New in Ablation Technology?

7 min.

Case Presentation: Complex BTK Intervention Patient

9 min.

R3 Vascular MAGNITUDE Bioresorbable Drug Eluting Scaffold

6 min.

Opportunities to Improve Outcomes: Perfusion Imaging for CLI

18 min.

When Amputation First Is the Right Decision in CLI: Making the Tough Decision?

6 min.

Complex Tibial Loop Reconstruction: A Step-by-step Guide to Success BTK and Below the Ankle

9 min.

Bioresorbable Stent Technology for BTK Disease: Putting the Trials Into Perspective

7 min.

Critical Assessment of the Tibial Arch Anatomy

6 min.

Real World Evidence About Paclitaxel Safety

9 min.

Tibiopedal Access/Intervention

7 min.

Deep Vein Arterialization

7 min.

Limb Perfusion Technology: Do We Have It Figured Out?

6 min.

New technology update in CLI: Atherectomy

8 min.

New technology update for CLI : Scaffolds

8 min.

Reflow Medical’s Temporary Spur DES System

3 min.

MOTIV BRS (REVA Vascular)

4 min.

APTITUDE PLLA BRS (R3 Vascular)

4 min.

Hybrid Nano-Coating DES for BTK Disease

6 min.

Addressing Microvascular Obstruction and No Reflow With a Novel Nanoscale Endovascular Image-Guided Interventional Tool (Pulse NanoMED)

4 min.

First Safety and Efficacy Study of the Misago Stent in Lower Extremity Endovascular Interventions via Radial Access Approach

8 min.

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

7 min.